Novavax completes submission of COVID vaccine candidate to WHO

By The Science Advisory Board staff writers

November 5, 2021 -- Novavax has completed its rolling submission to the World Health Organization (WHO) for emergency use listing of NVX-CoV2373, its COVID-19 vaccine candidate.

The company has completed its submission to WHO of all the modules required for the regulatory evaluation of its vaccine candidate, which is manufactured in partnership with the Serum Institute of India. Novavax said it will make further submissions to enable vaccine supply from additional manufacturing sites.

The company said it recently received authorization for its vaccine in Indonesia. It has submitted regulatory filings in the U.K., Australia, New Zealand, and Canada. Novavax said that it has also submitted data and modules in the European Union to support final regulatory review. Novavax expects to submit the complete package to the U.S. Food and Drug Administration by the end of the year.

Novavax submits COVID vaccine candidate to TGA
Novavax completed its rolling submission to the Therapeutic Goods Administration (TGA) for provisional approval of its COVID-19 vaccine candidate in Australia.
Novavax COVID-19 vaccine booster appears effective after primary vaccination
Novavax announced preliminary data indicating that a single booster dose of the company's recombinant nanoparticle protein-based COVID-19 vaccine drew...
Novavax touts COVID-19 vaccine results
Novavax is highlighting study results that demonstrate the efficacy of its COVID-19 vaccine, NVX-CoV2373, as well as a new COVID-19 vaccine it is developing...
Novavax posts positive preclinical results for flu/COVID-19 vaccine
Novavax is highlighting positive preclinical results for a combination influenza/COVID-19 vaccine.
Novavax COVID-19 vaccine to be included in combo vaccine study
Novavax announced it will participate in a newly expanded phase II trial to study NVX-CoV2373, its recombinant protein COVID-19 vaccine candidate. The...

Copyright © 2021 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter